Physician
Childrens Medical Group INC
Childrens Medical Group INC was paid $2.10M by Medicaid between Jan 2019 and Dec 2024, across 79 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider infoCHILDRENS MEDICAL GROUP INC
NORFOLK, VA 23513
NORFOLK, VA 23513
33aNPI1629546106assigned 11/02/2018
33bProvider typePediatrics Physician
28Total paid$2.10M
24GClaims80,212
24DCodes billed79
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Virginia
Rank by total paid#89 of 817
Median peer was paid$29K
This provider vs. median72×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ABSHIRE, KATHRYN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 7,078 | $180K | |
| 2020 | 8,884 | $221K | |
| 2021 | 15,298 | $398K | |
| 2022 | 17,117 | $451K | |
| 2023 | 15,235 | $401K | |
| 2024incomplete | 16,600 | $446K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 9,188 | 8,488 | $605K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 3,018 | 2,827 | $282K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 11% | 2,765 | 2,635 | $233K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 9.3% | 2,511 | 2,013 | $196K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 8.4% | 2,124 | 2,040 | $176K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.9% | 1,401 | 1,341 | $125K |
| 92551 | 2.8% | 5,549 | 5,297 | $59K | |
| 90686 | 2.0% | 3,566 | 3,355 | $43K | |
| 90651 | 2.0% | 1,675 | 1,601 | $42K | |
| 96127 | 1.6% | 6,304 | 5,479 | $34K | |
| 90670 | 1.0% | 1,344 | 1,277 | $22K | |
| 99310 | Prolong nursin fac eval 15m | <1% | 229 | 219 | $21K |
67 more codes
| 90633 | <1% | 1,465 | $18K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,767 | $17K |
| 96160 | <1% | 6,253 | $15K | |
| 90677 | <1% | 464 | $14K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 299 | $12K |
| 99174 | <1% | 2,161 | $12K | |
| 90697 | <1% | 576 | $11K | |
| 99188 | <1% | 490 | $11K | |
| 90698 | <1% | 812 | $10K | |
| 90680 | <1% | 713 | $10K | |
| 96161 | <1% | 4,120 | $10K | |
| 99173 | <1% | 3,428 | $9K | |
| 90656 | <1% | 455 | $9K | |
| 90734 | <1% | 465 | $9K | |
| 90671 | <1% | 316 | $8K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 228 | $8K |
| 0071A | <1% | 136 | $6K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 87 | $5K |
| 91321 | <1% | 195 | $5K | |
| 83655 | <1% | 407 | $5K | |
| 90744 | <1% | 446 | $5K | |
| 0001A | <1% | 112 | $5K | |
| 85018 | <1% | 1,716 | $4K | |
| 0002A | <1% | 91 | $4K | |
| 87428 | <1% | 69 | $4K | |
| 0072A | <1% | 81 | $3K | |
| 0081A | <1% | 113 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 76 | $3K |
| 0124A | <1% | 72 | $3K | |
| 90710 | <1% | 120 | $3K | |
| 91322 | <1% | 77 | $3K | |
| 1128F | <1% | 5,343 | $3K | |
| 99383 | <1% | 29 | $3K | |
| 90620 | <1% | 77 | $2K | |
| 90619 | <1% | 79 | $1K | |
| 0053A | <1% | 36 | $1K | |
| 0082A | <1% | 44 | $1K | |
| 90715 | <1% | 97 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 70 | $1K |
| 36416 | <1% | 2,480 | $1K | |
| 90696 | <1% | 59 | $764.44 | |
| 0073A | <1% | 15 | $675.20 | |
| 99000 | <1% | 367 | $621.49 | |
| 69210 | <1% | 24 | $578.45 | |
| 0083A | <1% | 15 | $492.80 | |
| 90716 | <1% | 39 | $479.04 | |
| 90700 | <1% | 30 | $337.15 | |
| 1127F | <1% | 913 | $325.00 | |
| 90648 | <1% | 26 | $282.22 | |
| 90707 | <1% | 24 | $270.05 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 15 | $240.89 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 19 | $192.89 |
| 80061 | Lipid panel | <1% | 59 | $169.63 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 13 | $154.90 |
| 90685 | <1% | 13 | $142.16 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 12 | $89.76 |
| 81003 | <1% | 27 | $77.45 | |
| 82962 | <1% | 12 | $34.24 | |
| 99051 | <1% | 44 | $23.71 | |
| 91308 | <1% | 203 | $1.63 | |
| 91307 | <1% | 380 | $1.04 | |
| 91312 | <1% | 70 | $0.44 | |
| 91305 | <1% | 144 | $0.29 | |
| 91300 | <1% | 326 | $0.27 | |
| G9920 | Screening performed and negative | 0% | 445 | $0.00 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 46 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 1,133 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialABSHIRE, KATHRYN (SENIOR VP/CFO)
Parent organizationCHILDRENS MEDICAL GROUP INC
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.